Search Results - "Arends, Tom J.H"
-
1
Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer
Published in European urology (01-06-2016)“…Abstract Background Despite adjuvant intravesical therapy, recurrences in non–muscle-invasive bladder cancer (NMIBC) are still high; therefore, new treatment…”
Get full text
Journal Article -
2
Combined chemohyperthermia: 10-year single center experience in 160 patients with nonmuscle invasive bladder cancer
Published in The Journal of urology (01-09-2014)“…Nonmuscle invasive bladder cancer is characterized by a high recurrence rate. New adjuvant treatments are needed to decrease this high number of recurrences…”
Get more information
Journal Article -
3
Management of Low-risk and Intermediate-risk Non–Muscle-invasive Bladder Carcinoma
Published in Hematology/oncology clinics of North America (01-04-2015)“…Non–muscle-invasive bladder cancer is a highly recurrent disease. The health care costs for non–muscle-invasive bladder cancer are a major burden for society…”
Get full text
Journal Article -
4
Pharmacokinetic, Pharmacodynamic, and Activity Evaluation of TMX-101 in a Multicenter Phase 1 Study in Patients With Papillary Non-Muscle-Invasive Bladder Cancer
Published in Clinical genitourinary cancer (01-06-2015)“…Micro-Abstract New intravesical therapies for non-muscle-invasive bladder cancer are strongly needed to decrease recurrence rates. In this study, the effective…”
Get full text
Journal Article -
5
Radical Cystectomy in a Dutch University Hospital: Long-Term Outcomes and Prognostic Factors in a Homogeneous Surgery-Only Series
Published in Clinical genitourinary cancer (01-06-2014)“…Micro-Abstract Limited survival data regarding muscle-invasive bladder cancer are available from outside the large tertiary referral centers. The aim of this…”
Get full text
Journal Article -
6
Apaziquone for Nonmuscle Invasive Bladder Cancer
Published in Urologic clinics of North America (01-02-2020)“…Apaziquone is an interesting drug for intravesical use in patients with nonmuscle invasive bladder cancer; however, more research is needed to prove its actual…”
Get full text
Journal Article -
7
Reply to Sławomir Poletajew, Piotr Radziszewski, Juan Palou Letter to the Editor re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046–52
Published in European urology (2016)Get full text
Journal Article -
8
Apaziquone for Nonmuscle Invasive Bladder Cancer: Where Are We Now?
Published in Urologic clinics of North America (01-02-2020)Get full text
Journal Article -
9
Reply to Harshit Garg, Brusabhanu Nayak and Prabhjot Singh's Letter to the Editor Re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046–52
Published in European urology (01-02-2019)Get full text
Journal Article -
10
Reply to Sławomir Poletajew, Piotr Radziszewski, Juan Palou’s Letter to the Editor re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046–52
Published in European urology (01-01-2017)Get full text
Journal Article -
11
Long-Term Experience with Radiofrequency-Induced Hyperthermia Combined with Intravesical Chemotherapy for Non-Muscle Invasive Bladder Cancer
Published in Cancers (20-01-2021)“…The recurrence rate of non-muscle invasive bladder cancer (NMIBC) is high, despite intravesical treatments. Importantly, patients are frequently unfit or…”
Get full text
Journal Article -
12
Intravesical radiofrequency induced hyperthermia enhances mitomycin C accumulation in tumour tissue
Published in International journal of hyperthermia (03-10-2018)“…Non-muscle invasive bladder cancer (NMIBC) is a highly recurrent disease with potential progression to muscle invasive disease despite the standard bladder…”
Get more information
Journal Article -
13
Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermia
Published in World journal of urology (01-10-2015)“…Objectives To explore whether urinary cytokine and chemokine (CK) levels differed between cold mitomycin-C (cold-MMC)-treated patients and chemohyperthermia…”
Get full text
Journal Article -
14
Expert review: an update in current and developing intravesical therapies for non-muscle-invasive bladder cancer
Published in Expert review of anticancer therapy (01-11-2013)“…Non-muscle-invasive bladder cancer is a highly prevalent disease and recurrences, after initial therapy, are common. Consequently, the healthcare costs for…”
Get full text
Journal Article -
15
Middellangetermijnoverleving na open versus robotgeassisteerde radicale cystectomie in Nederland: resultaten van de ‘SNAPSHOT’ cystectomie
Published in Tijdschrift voor urologie (01-12-2023)“…Er is onvoldoende bekend over de middellangetermijnoverleving van niet-gemetastaseerd spierinvasieve blaaskanker (SIBC) na open (ORC) versus robotgeassisteerde…”
Get full text
Journal Article